Palantir Technologies

Health minister James Frith warned that public mistrust of Palantir may be reducing patients' willingness to share NHS data after 60,000 more people opted out between mid‑May and mid‑July. The government is considering whether to terminate the company's £330m contract to run the federated data platform amid concerns over Palantir's external links and value for money. Palantir and NHS England say the technology has improved waiting‑list metrics, but officials and watchdogs say causation is unproven and trusts are no longer required to use the platform. » More on theguardian.com

A $100 investment in Palantir a year ago would now equal 0.653 shares and be worth $113.86, representing a gain of 13.86%. The price per share was $174.33 on 04.09.2026; Palantir most recently reached a market capitalization of $419.33 billion. The calculation does not take stock splits and dividends into account. » More on finanzen.net

Palantir shares jumped 7.7% after PwC US broadened an alliance centered on enterprise AI, M&A and ERP modernization, touting an AI-native deals platform that could speed transactions up to 50% and cut one-time costs by as much as 45% though no new contract value was disclosed. The move aligns with Palantir’s momentum after Q2 revenue grew 93% to $1.94 billion and strong U.S. commercial growth, but valuation, receivables concentration, stock-based compensation and competition from cloud providers and consultants remain risks. Investors will look for commercial proof—named deployments, renewals, implementation times and revenue per delivery employee—to confirm whether the partnership produces repeatable, margin-accretive growth. » More on finance.yahoo.com